Technology | Ultrasound Imaging | March 26, 2018

Samsung Unveils New RS85A Ultrasound System at AIUM 2018

The Samsung RS85A premium ultrasound system combines exceptional image quality with advanced ergonomics

Samsung Unveils New RS85A Ultrasound System at AIUM 2018

The RS85A MV-Flow allows for visualization of slow-flow micro vascularized structures, which can be difficult to assess with conventional power Doppler ultrasound. Photo courtesy of Business Wire.

Samsung RS85A Ultrasound Features S-Shearwave Imaging

The RS85A S-Shearwave Imaging provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography. Photo courtesy of Business Wire.

March 26, 2018 — Samsung NeuroLogica announced the Samsung RS85A ultrasound system has received U.S. Food and Drug Administration (FDA) 510(k) clearance and will be unveiled at the American Institute of Ultrasound in Medicine (AIUM) in New York City, March 24-28, 2018. The RS85A is a premium general imaging with superior image quality and usability, according to Samsung NeuroLogica President and CEO Philip Sullivan.

The new ultrasound system features an array of improvements, including:

  • MV-Flow: Allows for visualization of slow-flow micro-vascularized structures, which can be difficult to assess with conventional power Doppler ultrasound. It also provides clinicians an additional way to check lesions for indications of cancer or inflammation;
  • S-Shearwave Imaging: Provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography, which may help increase the accuracy of diagnosis for breast and liver diseases;
  • CEUS+: Diagnoses and characterizes lesions in the liver using a contrast agent in adult and pediatric populations; and
  • S-Fusion: Enables simultaneous localization of a lesion using real-time ultrasound in conjunction with other volumetric imaging modalities such as magnetic resonance imaging (MRI) or computed tomography (CT), while expanding its capabilities to the prostate gland for precise, targeted biopsy guidance.

The RS85A was also developed to help decrease user-fatigue and repetitive motions with an enhanced monitor arm and increased range of motion and tilt. These improvements allow the user to position the monitor for optimal viewing and control. Additionally, multi-step actions have been combined into a single step to help reduce keystrokes and repetitive user interface interactions.

The system comes with a five-year warranty standard at no additional cost.

In addition to the introduction of the RS85A at AIUM 2018, Samsung will showcase additional products in their comprehensive ultrasound portfolio, including the WS80A with Elite, its premium women’s health ultrasound system, the HS60, HS40 and the HM70A with Plus.

For more information: www.neurologica.com

Related AIUM Content

Canon Aplio i600 Ultrasound System Receives FDA Clearance

SonoSim Launches Cloud-Based OB-GYN Ultrasound Training Modules

 

Related Content

Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019
News | Enterprise Imaging | February 15, 2019
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
Epiq Elite for Obstetrics and Gynecology delivers high image quality and lifelike 3-D scans

The Epiq Elite for Obstetrics & Gynecology. Image courtesy of Philips Healthcare.

Technology | Ultrasound Imaging | February 07, 2019
Philips announced the launch of the Epiq Elite ultrasound system, a new premium ultrasound that combines the latest...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi
Konica Minolta Releases Sonimage HS1 Ultrasound Software Upgrade
News | Ultrasound Imaging | January 31, 2019
Konica Minolta Healthcare Americas Inc. released a new software upgrade for the Sonimage HS1 Ultrasound System that...
QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids
News | Ultrasound Women's Health | January 30, 2019
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission
ASE Releases New Guide to Performing Comprehensive Transthoracic Echo Exams
News | Cardiovascular Ultrasound | January 21, 2019
January 21, 2019 – Medical experts have released “...
Triton College Launching Vascular Technology in Sonography Certificate Program
News | Ultrasound Imaging | January 09, 2019
Starting in spring 2019, Triton College’s Vascular Technology in Sonography Certificate Program will help working...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...